Cahaba Wealth Management’s Perspective Therapeutics CATX Stock Holding History

Cahaba Wealth Management’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,500	Closed	-$114K	–	81
2021 Q1	$114K	Hold	10,500	–	–	0.02%	89
2020 Q4	$235K	Hold	10,500	–	–	0.04%	84
2020 Q3	$61K	Hold	10,500	–	–	0.01%	77
2020 Q2	$69K	Hold	10,500	–	–	0.01%	77
2020 Q1	$55K	Hold	10,500	–	–	0.01%	72
2019 Q4	$65K	Buy	10,500 +5,000	+91%	+$21.9K	0.01%	79
2019 Q3	$17K	Hold	5,500	–	–	﹤0.01%	74
2019 Q2	$22K	Hold	5,500	–	–	0.01%	74
2019 Q1	$20K	Hold	5,500	–	–	0.01%	71
2018 Q4	$16K	Hold	5,500	–	–	﹤0.01%	71
2018 Q3	$28K	Hold	5,500	–	–	0.01%	69
2018 Q2	$29K	Hold	5,500	–	–	0.01%	65
2018 Q1	$22K	Hold	5,500	–	–	0.01%	61
2017 Q4	$21K	Buy	+5,500	New	+$25.6K	0.01%	59

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HPWM

Highland Private Wealth Management Bellevue, Washington $620M AUM 18.88% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cahaba Wealth Management's CATX Position: Q2 2021 in Review

Cahaba Wealth Management sold out of Perspective Therapeutics (CATX) in Q2 2021, closing a stake of 10,500 shares — an estimated $114K sold.

Cahaba Wealth Management first reported a position in CATX in Q4 2017 and held it in 14 quarters. The position peaked at $235K in Q4 2020. 48 funds tracked by Wall St. Rank hold CATX as of Q2 2021.

Cahaba Wealth Management reported no remaining Perspective Therapeutics position as of Q2 2021 after selling out during the quarter.
Cahaba Wealth Management sold 10,500 Perspective Therapeutics shares in Q2 2021, an estimated $114K.
Cahaba Wealth Management first reported a position in Perspective Therapeutics in Q4 2017 and held it in 14 quarters.
Cahaba Wealth Management's Perspective Therapeutics position peaked at $235K in Q4 2020.
48 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2021.

Based on Cahaba Wealth Management's 13F filing for Q2 2021, filed 10 Aug 2021.